Tremblay et al. (2025) “A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels” Nature Medicine.
DOI: 10.1038/s41591-025-03508-x
Read about Tremblay et al. (2025) “A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels” Nature Medicine.
PUBLICATION ALERT: High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays
Read about PUBLICATION ALERT: High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays
Imiolek et al. (2025) “High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays” Analytical Chemistry.
DOI: 10.1021/acs.analchem.4c06296
Read about Imiolek et al. (2025) “High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays” Analytical Chemistry.
PUBLICATION ALERT: Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by in situ delivery of RNA lipid nanoparticles
Read about PUBLICATION ALERT: Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by in situ delivery of RNA lipid nanoparticles
Banda et al. (2025) “Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by in situ delivery of RNA lipid nanoparticles” Molecular Therapy.
DOI: 10.1016/j.omtn.2024.102423
Read about Banda et al. (2025) “Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by in situ delivery of RNA lipid nanoparticles” Molecular Therapy.
Smith et al. (2024) “Impact of metabolic states on SARS-CoV-2 vaccine responses in mouse models of obesity and diabetes” MDPI.
Read about Smith et al. (2024) “Impact of metabolic states on SARS-CoV-2 vaccine responses in mouse models of obesity and diabetes” MDPI.
Acuitas Scientist Presented at 3rd LNP Immunogenicity & Toxicity Summit
Read about Acuitas Scientist Presented at 3rd LNP Immunogenicity & Toxicity Summit
Abt et al. (2024) “Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire” PNAS.
Read about Abt et al. (2024) “Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire” PNAS.
Acuitas Therapeutics Named One of Canada’s Most Admired™ Corporate Cultures by Waterstone
Read about Acuitas Therapeutics Named One of Canada’s Most Admired™ Corporate Cultures by Waterstone
Acuitas Therapeutics Honoured With Philanthropic Award
Read about Acuitas Therapeutics Honoured With Philanthropic Award
Acuitas Scientists Highlight Next Generation LNP Technology at International mRNA Health Conference
Read about Acuitas Scientists Highlight Next Generation LNP Technology at International mRNA Health Conference
Castruccio Castracani et al. (2024) “An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA” Blood.
Read about Castruccio Castracani et al. (2024) “An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA” Blood.